Pharmaceutical Executive
Pharmaceutical Executive
Pharmaceutical Executive Podcast
Episode 42: Establishing a New Drug Therapy
14 minutes Posted Oct 17, 2019 at 1:00 pm.
0:00
14:38
Download MP3
Show notes
Pharm Exec editors interview Mark Glickman, Chief Commercial Officer of Esperion Therapeutics. Glickman discusses the overall cholesterol-lowering space and how it’s planning to add a new therapeutic option for patients, what it means to establish a new therapy in a statin-dominated market, market research approaches, and more.